Skip to main content
. 2016 Dec 29;11(12):e0168958. doi: 10.1371/journal.pone.0168958

Fig 1. Disease activity as measured by BASDAI and serum CRP of the two treatment groups during the follow up.

Fig 1

Error bars indicate 95% confidential intervals.